BET Comment
Bet Comment
Your Name
Your Email
Subject:
Comment on: 03252 How can we better predict which patients are at risk of persisting symptoms months after a mild TBI, including assessment with newer technologies including MRI, biomarkers and other emerging strategies, who may benefit from follow-up, early management or inclusion into clinical trials.
Comments: